Review
Open access
Aug 2026
Hypoimmune platforms: from rejection to immune evasion and regulatory implications
This review summarizes current strategies for engineering immune-evasive grafts that simultaneously suppress adaptive and innate immune responses and outlines the safety considerations and remaining limitations in immune evasion that must be addressed to enable clinical implementation.
F. Campo, Maria Irene Bellini, Hanne Scholz et al.
· Transplant International · 1 citation